Profile | GDS4284 / 209269_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 4683.39 | 93 |
GSM687648 | Patient 402 control | 6153.71 | 95 |
GSM687653 | Patient 403 control | 7666.33 | 96 |
GSM687658 | Patient 404 control | 5110.67 | 93 |
GSM687663 | Patient 411 control | 6961.88 | 95 |
GSM687668 | Patient 422 control | 6533.53 | 95 |
GSM687673 | Patient 424 control | 6260.65 | 95 |
GSM687678 | Patient 425 control | 3417.8 | 90 |
GSM687683 | Patient 427 control | 6305.34 | 95 |
GSM687688 | Patient 428 control | 4063.46 | 92 |
GSM687695 | Patient 441 control | 1641.42 | 83 |
GSM687699 | Patient 443 control | 6189.51 | 95 |
GSM687704 | Patient 444 control | 3152.56 | 89 |
GSM687707 | Patient 448 control | 3797.82 | 91 |
GSM687712 | Patient 449 control | 4153.87 | 92 |
GSM687719 | Patient 450 control | 4557.15 | 93 |
GSM687724 | Patient 451 control | 5573.08 | 94 |
GSM687728 | Patient 452 control | 3262.7 | 90 |
GSM687646 | Patient 401 treated 24h | 4345.67 | 92 |
GSM687649 | Patient 402 treated 24h | 5718.58 | 94 |
GSM687665 | Patient 411 treated 24h | 6780.23 | 95 |
GSM687651 | Patient 402 treated 4 weeks | 6778.2 | 95 |
GSM687667 | Patient 411 treated 4 weeks | 7280.55 | 96 |
GSM687670 | Patient 422 treated 24h | 6159.82 | 95 |
GSM687671 | Patient 422 treated 4 weeks | 6956.17 | 95 |
GSM687654 | Patient 403 treated 24h | 7235.64 | 96 |
GSM687675 | Patient 424 treated 24h | 6346.6 | 95 |
GSM687685 | Patient 427 treated 24h | 6703.22 | 95 |
GSM687656 | Patient 403 treated 4 weeks | 8909.64 | 97 |
GSM687677 | Patient 424 treated 4 weeks | 6128.04 | 95 |
GSM687687 | Patient 427 treated 4 weeks | 6746.9 | 95 |
GSM687692 | Patient 428 treated 4h | 3350.47 | 90 |
GSM687716 | Patient 449 treated 4h | 4543.32 | 92 |
GSM687722 | Patient 450 treated 4h | 3572.21 | 91 |
GSM687680 | Patient 425 treated 24h | 2769 | 88 |
GSM687690 | Patient 428 treated 24h | 2523.97 | 87 |
GSM687700 | Patient 443 treated 24h | 2376.09 | 87 |
GSM687705 | Patient 444 treated 24h | 1796.57 | 83 |
GSM687714 | Patient 449 treated 24h | 4012.41 | 91 |
GSM687721 | Patient 450 treated 24h | 3599.64 | 91 |
GSM687682 | Patient 425 treated 4 weeks | 2903.83 | 88 |
GSM687694 | Patient 428 treated 4 weeks | 4651.49 | 93 |
GSM687702 | Patient 443 treated 4 weeks | 5228 | 94 |
GSM687718 | Patient 449 treated 4 weeks | 4975.91 | 93 |
GSM687723 | Patient 450 treated 4 weeks | 4478.71 | 92 |
GSM687661 | Patient 404 treated 4h | 4088.56 | 92 |
GSM687710 | Patient 448 treated 4h | 4380.82 | 92 |
GSM687726 | Patient 451 treated 4h | 5900.82 | 95 |
GSM687730 | Patient 452 treated 4h | 316.475 | 43 |
GSM687660 | Patient 404 treated 24h | 2080.7 | 86 |
GSM687697 | Patient 441 treated 24h | 2381.07 | 87 |
GSM687709 | Patient 448 treated 24h | 3432.06 | 90 |
GSM687725 | Patient 451 treated 24h | 4394.53 | 92 |
GSM687729 | Patient 452 treated 24h | 3464.95 | 91 |
GSM687727 | Patient 451 treated 4 weeks | 5531.13 | 94 |
GSM687731 | Patient 452 treated 4 weeks | 3307.95 | 90 |